NuScale Power Stock Slumps as UBS Predicts 40% Decline Amid Regulatory Uncertainty

NuScale Power's stock has taken a hit after UBS downgraded it to 'Sell' and predicted a 40% decline in value. The downgrade comes as investors are growing increasingly cautious about the prospects of Small Modular Reactors (SMRs) like NuScale's. According to UBS, there is a lack of clarity on the regulatory framework for SMRs, which could impact their adoption and revenue potential.

NuScale has been working with the US Department of Energy to advance its SMR technology, but investors are still uncertain about the timeline and costs associated with commercialization. The company's stock price has already taken a hit in recent months, falling from around $10 per share to below $5. UBS' downgrade is likely to exacerbate this trend.

NuScale has maintained that it is on track to meet its development milestones and that it has secured significant funding commitments from investors. However, the uncertainty surrounding regulatory approvals and market demand may continue to weigh on the stock price in the near term.